Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.

Détails

Ressource 1Télécharger: 36327219_BIB_05AB909EB191.pdf (2816.57 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_05AB909EB191
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.
Périodique
PLoS genetics
Auteur⸱e⸱s
Butler-Laporte G., Povysil G., Kosmicki J.A., Cirulli E.T., Drivas T., Furini S., Saad C., Schmidt A., Olszewski P., Korotko U., Quinodoz M., Çelik E., Kundu K., Walter K., Jung J., Stockwell A.D., Sloofman L.G., Jordan D.M., Thompson R.C., Del Valle D., Simons N., Cheng E., Sebra R., Schadt E.E., Kim-Schulze S., Gnjatic S., Merad M., Buxbaum J.D., Beckmann N.D., Charney A.W., Przychodzen B., Chang T., Pottinger T.D., Shang N., Brand F., Fava F., Mari F., Chwialkowska K., Niemira M., Pula S., Baillie J.K., Stuckey A., Salas A., Bello X., Pardo-Seco J., Gómez-Carballa A., Rivero-Calle I., Martinón-Torres F., Ganna A., Karczewski K.J., Veerapen K., Bourgey M., Bourque G., Eveleigh R.J., Forgetta V., Morrison D., Langlais D., Lathrop M., Mooser V., Nakanishi T., Frithiof R., Hultström M., Lipcsey M., Marincevic-Zuniga Y., Nordlund J., Schiabor Barrett K.M., Lee W., Bolze A., White S., Riffle S., Tanudjaja F., Sandoval E., Neveux I., Dabe S., Casadei N., Motameny S., Alaamery M., Massadeh S., Aljawini N., Almutairi M.S., Arabi Y.M., Alqahtani S.A., Al Harthi F.S., Almutairi A., Alqubaishi F., Alotaibi S., Binowayn A., Alsolm E.A., El Bardisy H., Fawzy M., Cai F., Soranzo N., Butterworth A., Geschwind D.H., Arteaga S., Stephens A., Butte M.J., Boutros P.C., Yamaguchi T.N., Tao S., Eng S., Sanders T., Tung P.J., Broudy M.E., Pan Y., Gonzalez A., Chavan N., Johnson R., Pasaniuc B., Yaspan B., Smieszek S., Rivolta C., Bibert S., Bochud P.Y., Dabrowski M., Zawadzki P., Sypniewski M., Kaja E., Chariyavilaskul P., Nilaratanakul V., Hirankarn N., Shotelersuk V., Pongpanich M., Phokaew C., Chetruengchai W., Tokunaga K., Sugiyama M., Kawai Y., Hasegawa T., Naito T., Namkoong H., Edahiro R., Kimura A., Ogawa S., Kanai T., Fukunaga K., Okada Y., Imoto S., Miyano S., Mangul S., Abedalthagafi M.S., Zeberg H., Grzymski J.J., Washington N.L., Ossowski S., Ludwig K.U., Schulte E.C., Riess O., Moniuszko M., Kwasniewski M., Mbarek H., Ismail S.I., Verma A., Goldstein D.B., Kiryluk K., Renieri A., Ferreira MAR, Richards J.B.
Collaborateur⸱rice⸱s
COVID-19 Host Genetics Initiative, DeCOI Host Genetics Group, GEN-COVID Multicenter Study (Italy), Mount Sinai Clinical Intelligence Center, GEN-COVID consortium (Spain), GenOMICC Consortium, Japan COVID-19 Task Force, Regeneron Genetics Center
ISSN
1553-7404 (Electronic)
ISSN-L
1553-7390
Statut éditorial
Publié
Date de publication
11/2022
Peer-reviewed
Oui
Volume
18
Numéro
11
Pages
e1010367
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Résumé
Host genetics is a key determinant of COVID-19 outcomes. Previously, the COVID-19 Host Genetics Initiative genome-wide association study used common variants to identify multiple loci associated with COVID-19 outcomes. However, variants with the largest impact on COVID-19 outcomes are expected to be rare in the population. Hence, studying rare variants may provide additional insights into disease susceptibility and pathogenesis, thereby informing therapeutics development. Here, we combined whole-exome and whole-genome sequencing from 21 cohorts across 12 countries and performed rare variant exome-wide burden analyses for COVID-19 outcomes. In an analysis of 5,085 severe disease cases and 571,737 controls, we observed that carrying a rare deleterious variant in the SARS-CoV-2 sensor toll-like receptor TLR7 (on chromosome X) was associated with a 5.3-fold increase in severe disease (95% CI: 2.75-10.05, p = 5.41x10-7). This association was consistent across sexes. These results further support TLR7 as a genetic determinant of severe disease and suggest that larger studies on rare variants influencing COVID-19 outcomes could provide additional insights.
Mots-clé
Humans, Exome/genetics, Genome-Wide Association Study, COVID-19/genetics, Genetic Predisposition to Disease, Toll-Like Receptor 7/genetics, SARS-CoV-2/genetics
Pubmed
Web of science
Open Access
Oui
Création de la notice
23/11/2022 10:23
Dernière modification de la notice
23/01/2024 8:20
Données d'usage